gamma-aminobutyric acid has been researched along with Atrophy in 45 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To preliminarily compare the efficacy of pregabalin with that of placebo on the cerebellar signs caused by cortical cerebellar atrophy (CCA)." | 9.12 | Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy. ( Benavente, I; Gazulla, J, 2007) |
| "The aim of this work was to investigate the efficacy of the GABAergic drug gabapentin in the treatment of the cerebellar signs caused by cortical cerebellar atrophy (CCA)." | 9.11 | Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study. ( Benavente, I; Errea, JM; Gazulla, J; Tordesillas, CJ, 2004) |
| "Gabapentin has been demonstrated to be capable of improving the cerebellar signs in cases of CCA, after single doses and after continued administration of the drug during 4 weeks." | 6.71 | Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study. ( Benavente, I; Errea, JM; Gazulla, J; Tordesillas, CJ, 2004) |
| "Mirtazapine was more effective than desipramine in restoring somatosensory cortex thickness by fully rescuing pyramidal neurons dendritic arborization and spine density." | 5.43 | Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice. ( Baj, G; Bernareggi, A; Bittolo, T; Deiana, C; Ferrazzo, S; Raminelli, CA; Tongiorgi, E; Vaghi, V, 2016) |
| "No causal treatment of ataxias is available at the moment, and so symptomatic and disease-modifying therapies are regarded as a reliable possibility for this complex group of movement disorders." | 5.35 | Gabapentin treatment improves motor coordination in a mice model of progressive ataxia. ( Calzà, L; D'Intino, G; Ferraro, L; Giardino, L; Gusciglio, M; Massella, A; Sivilia, S, 2009) |
| "Acute seizure activity was behaviorally scored and hemispheric brain atrophy measured." | 5.35 | Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia. ( Comi, AM; Johnston, MV; Kadam, SD; Mulholland, JD; Traa, BS, 2008) |
| "Gamma-aminobutyric acid (GABA) was administered orally to rats for 60 d after excision of five-sixths of their kidney volume." | 5.34 | Gamma-aminobutyric acid specifically inhibits progression of tubular fibrosis and atrophy in nephrectomized rats. ( Kim, M; Sasaki, S; Tohda, C; Yokozawa, T, 2007) |
| "To preliminarily compare the efficacy of pregabalin with that of placebo on the cerebellar signs caused by cortical cerebellar atrophy (CCA)." | 5.12 | Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy. ( Benavente, I; Gazulla, J, 2007) |
| "The aim of this work was to investigate the efficacy of the GABAergic drug gabapentin in the treatment of the cerebellar signs caused by cortical cerebellar atrophy (CCA)." | 5.11 | Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study. ( Benavente, I; Errea, JM; Gazulla, J; Tordesillas, CJ, 2004) |
| "Some recent autopsy studies indicate that gamma-aminobutyric acid (GABA) function is decreased in brain areas that involve some of the well-described structural changes observed in schizophrenia." | 3.70 | GABA and brain abnormalities in schizophrenia. ( Barry, EJ; Gurklis, JA; Kelley, ME; Kramer, GL; Peters, JL; Petty, F; van Kammen, DP; Yao, JK, 1998) |
| "These results suggest a participation of autoimmunity in the pathogenesis of some cases of sporadic cerebellar cortical atrophy and the involvement of the cerebellar gamma-aminobutyric acid-ergic system in the pathogenesis of this disease." | 3.69 | Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. ( Aguera, M; Belin, MF; Honnorat, J; Thivolet, C; Trouillas, P, 1995) |
| "Seizures in a term infant with Ohtahara syndrome, associated with polymicrogyria, and a pre-term neonate with similar clinical features, failed to respond to conventional anticonvulsants, but were controlled with vigabatrin monotherapy." | 3.69 | Vigabatrin monotherapy in resistant neonatal seizures. ( Barwick, DD; Baxter, PS; Gardner-Medwin, D; Ince, P; Livingston, J; Murdoch-Eaton, D, 1995) |
| "Gabapentin has been demonstrated to be capable of improving the cerebellar signs in cases of CCA, after single doses and after continued administration of the drug during 4 weeks." | 2.71 | Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study. ( Benavente, I; Errea, JM; Gazulla, J; Tordesillas, CJ, 2004) |
| "Posttraumatic stress disorder (PTSD) is a trauma and stressor-related disorder that results in complex somatic, cognitive, affective and behavioural effects, after exposure to traumatic event(s)." | 2.58 | Systematic review of in-vivo neuro magnetic resonance spectroscopy for the assessment of posttraumatic stress disorder. ( Mountford, C; Quadrelli, S; Ramadan, S, 2018) |
| " Therefore, in women with a uterus, it is recommended that physicians prescribe combination therapy only to treat menopausal symptoms such as vasomotor symptoms (hot flashes) and vaginal atrophy, using the smallest effective dosage for the shortest possible duration." | 2.53 | Hormone Therapy and Other Treatments for Symptoms of Menopause. ( Crider, M; Hill, DA; Hill, SR, 2016) |
| "Although estrogen is the most effective treatment for hot flashes, nonhormonal alternatives such as low-dose paroxetine, venlafaxine, and gabapentin are effective alternatives." | 2.53 | Hormone Therapy and Other Treatments for Symptoms of Menopause. ( Crider, M; Hill, DA; Hill, SR, 2016) |
| "Animal models of Batten disease and other neuronal storage disorders offer important opportunities to study the pathogenesis of brain dysfunction in this family of diseases." | 2.39 | Pathogenesis of brain dysfunction in Batten disease. ( Jolly, RD; March, PA; Schroeder, CE; Walkley, SU; Wurzelmann, S, 1995) |
| "Mirtazapine was more effective than desipramine in restoring somatosensory cortex thickness by fully rescuing pyramidal neurons dendritic arborization and spine density." | 1.43 | Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice. ( Baj, G; Bernareggi, A; Bittolo, T; Deiana, C; Ferrazzo, S; Raminelli, CA; Tongiorgi, E; Vaghi, V, 2016) |
| "We have generated a FTLD-U mouse model (CaMKII-TDP-43 Tg) in which TDP-43 is transgenically overexpressed in the forebrain resulting in phenotypic characteristics mimicking those of FTLD-U." | 1.36 | Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. ( Chien, WL; Cho, KH; Fang, YH; Fu, WM; Lin, CP; Shen, CK; Tsai, KJ; Wang, WT; Wu, TW; Yang, CH, 2010) |
| "No causal treatment of ataxias is available at the moment, and so symptomatic and disease-modifying therapies are regarded as a reliable possibility for this complex group of movement disorders." | 1.35 | Gabapentin treatment improves motor coordination in a mice model of progressive ataxia. ( Calzà, L; D'Intino, G; Ferraro, L; Giardino, L; Gusciglio, M; Massella, A; Sivilia, S, 2009) |
| " For this purpose we conducted a dose-response study at concentrations of AMPA between 0." | 1.35 | Pattern of injury with a graded excitotoxic insult and ensuing chronic medial septal damage in the rat brain. ( Andrés, N; Batlle, M; Mahy, N; Malpesa, Y; Prats, A; Pugliese, M; Rodríguez, MJ, 2009) |
| "Acute seizure activity was behaviorally scored and hemispheric brain atrophy measured." | 1.35 | Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia. ( Comi, AM; Johnston, MV; Kadam, SD; Mulholland, JD; Traa, BS, 2008) |
| "Gamma-aminobutyric acid (GABA) was administered orally to rats for 60 d after excision of five-sixths of their kidney volume." | 1.34 | Gamma-aminobutyric acid specifically inhibits progression of tubular fibrosis and atrophy in nephrectomized rats. ( Kim, M; Sasaki, S; Tohda, C; Yokozawa, T, 2007) |
| "Infantile neuronal ceroid lipofuscinosis (INCL) is one of a group of fatal hereditary lysosomal storage disorders." | 1.32 | Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. ( Bible, E; Cooper, JD; Gupta, P; Hofmann, SL, 2004) |
| "EEG showed typical hypsarrhythmia in 8 cases, asymmetrical hypsarrhythmia in 1 case and modified hypsarrhythmia in another case." | 1.30 | [West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment]. ( Caraballo, R; Cersósimo, R; Fejerman, N; Intruvini, S; Pociecha, J, 1997) |
| "Pyridoxine dependency is an uncommon familial cause of intractable seizures in newborns and infants." | 1.30 | Longitudinal MRI findings in pyridoxine-dependent seizures. ( Gospe, SM; Hecht, ST, 1998) |
| "A patient with adult onset Huntington's disease (HD) and prominent action myoclonus is described." | 1.29 | Adult onset myoclonic Huntington's disease. ( Binelli, S; Carella, F; Ciano, C; Girotti, F; Oliva, D; Scaioli, V, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (17.78) | 18.7374 |
| 1990's | 10 (22.22) | 18.2507 |
| 2000's | 17 (37.78) | 29.6817 |
| 2010's | 7 (15.56) | 24.3611 |
| 2020's | 3 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zargani, M | 1 |
| Ramirez-Campillo, R | 1 |
| Arabzadeh, E | 1 |
| Mancini, V | 1 |
| Saleh, MG | 1 |
| Delavari, F | 1 |
| Bagautdinova, J | 1 |
| Eliez, S | 1 |
| Blicher, JU | 1 |
| Eskildsen, SF | 1 |
| Stærmose, TG | 1 |
| Møller, AT | 1 |
| Figlewski, K | 1 |
| Near, J | 1 |
| Srivastava, I | 1 |
| Vazquez-Juarez, E | 1 |
| Henning, L | 1 |
| Gómez-Galán, M | 1 |
| Lindskog, M | 1 |
| Quadrelli, S | 1 |
| Mountford, C | 1 |
| Ramadan, S | 1 |
| Pintana, H | 1 |
| Lietzau, G | 1 |
| Augestad, IL | 1 |
| Chiazza, F | 1 |
| Nyström, T | 1 |
| Patrone, C | 1 |
| Darsalia, V | 1 |
| Bittolo, T | 1 |
| Raminelli, CA | 1 |
| Deiana, C | 1 |
| Baj, G | 1 |
| Vaghi, V | 1 |
| Ferrazzo, S | 1 |
| Bernareggi, A | 1 |
| Tongiorgi, E | 1 |
| Nascimento-Alves, P | 1 |
| Fernandes-Silva, H | 1 |
| Aragão-Homem, C | 1 |
| Geraldes, R | 1 |
| Fonseca, AC | 1 |
| Hill, DA | 1 |
| Crider, M | 1 |
| Hill, SR | 1 |
| Sargin, D | 1 |
| Hassouna, I | 1 |
| Sperling, S | 1 |
| Sirén, AL | 1 |
| Ehrenreich, H | 1 |
| Massella, A | 1 |
| Gusciglio, M | 1 |
| D'Intino, G | 1 |
| Sivilia, S | 1 |
| Ferraro, L | 1 |
| Calzà, L | 1 |
| Giardino, L | 1 |
| Rodríguez, MJ | 1 |
| Prats, A | 1 |
| Malpesa, Y | 1 |
| Andrés, N | 1 |
| Pugliese, M | 1 |
| Batlle, M | 1 |
| Mahy, N | 1 |
| Tsai, KJ | 1 |
| Yang, CH | 1 |
| Fang, YH | 1 |
| Cho, KH | 1 |
| Chien, WL | 1 |
| Wang, WT | 1 |
| Wu, TW | 1 |
| Lin, CP | 1 |
| Fu, WM | 1 |
| Shen, CK | 1 |
| Gibson, KM | 1 |
| Gupta, M | 1 |
| Pearl, PL | 1 |
| Tuchman, M | 1 |
| Vezina, LG | 1 |
| Snead, OC | 1 |
| Smit, LM | 1 |
| Jakobs, C | 1 |
| Bible, E | 1 |
| Gupta, P | 1 |
| Hofmann, SL | 1 |
| Cooper, JD | 1 |
| Gazulla, J | 2 |
| Errea, JM | 1 |
| Benavente, I | 2 |
| Tordesillas, CJ | 1 |
| Horvath, J | 1 |
| Coeytaux, A | 1 |
| Jallon, P | 1 |
| Landis, T | 1 |
| Temperli, P | 1 |
| Burkhard, PR | 1 |
| Economides, JR | 1 |
| Horton, JC | 1 |
| Coutin-Churchman, P | 1 |
| Moreno, R | 1 |
| Añez, Y | 1 |
| Vergara, F | 1 |
| Sasaki, S | 1 |
| Tohda, C | 1 |
| Kim, M | 1 |
| Yokozawa, T | 1 |
| Vutskits, L | 1 |
| Gascon, E | 1 |
| Potter, G | 1 |
| Tassonyi, E | 1 |
| Kiss, JZ | 1 |
| Sagredo, O | 1 |
| Ramos, JA | 1 |
| Decio, A | 1 |
| Mechoulam, R | 1 |
| Fernández-Ruiz, J | 1 |
| Traa, BS | 1 |
| Mulholland, JD | 1 |
| Kadam, SD | 1 |
| Johnston, MV | 1 |
| Comi, AM | 1 |
| Cavus, I | 1 |
| Pan, JW | 1 |
| Hetherington, HP | 1 |
| Abi-Saab, W | 1 |
| Zaveri, HP | 1 |
| Vives, KP | 1 |
| Krystal, JH | 1 |
| Spencer, SS | 1 |
| Spencer, DD | 1 |
| Marc, RE | 1 |
| Jones, BW | 1 |
| Watt, CB | 1 |
| Vazquez-Chona, F | 1 |
| Vaughan, DK | 1 |
| Organisciak, DT | 1 |
| Perry, TL | 3 |
| Kish, SJ | 2 |
| Hansen, S | 2 |
| Currier, RD | 2 |
| Snyder, SH | 1 |
| Yamamoto, M | 1 |
| Otsuki, S | 1 |
| Miyake, K | 1 |
| Namba, R | 1 |
| Christensen, SE | 1 |
| Dupont, E | 1 |
| Mondrup, K | 1 |
| Olivarius, BF | 1 |
| Orskov, H | 1 |
| Hornykiewicz, O | 1 |
| Holzbach, U | 1 |
| Hanefeld, F | 1 |
| Helms, G | 1 |
| Hänicke, W | 1 |
| Frahm, J | 1 |
| Walkley, SU | 1 |
| March, PA | 1 |
| Schroeder, CE | 1 |
| Wurzelmann, S | 1 |
| Jolly, RD | 1 |
| Honnorat, J | 1 |
| Trouillas, P | 1 |
| Thivolet, C | 1 |
| Aguera, M | 1 |
| Belin, MF | 1 |
| Baxter, PS | 1 |
| Gardner-Medwin, D | 1 |
| Barwick, DD | 1 |
| Ince, P | 1 |
| Livingston, J | 1 |
| Murdoch-Eaton, D | 1 |
| Carella, F | 1 |
| Scaioli, V | 1 |
| Ciano, C | 1 |
| Binelli, S | 1 |
| Oliva, D | 1 |
| Girotti, F | 1 |
| Caraballo, R | 1 |
| Cersósimo, R | 1 |
| Intruvini, S | 1 |
| Pociecha, J | 1 |
| Fejerman, N | 1 |
| van Kammen, DP | 1 |
| Petty, F | 1 |
| Kelley, ME | 1 |
| Kramer, GL | 1 |
| Barry, EJ | 1 |
| Yao, JK | 1 |
| Gurklis, JA | 1 |
| Peters, JL | 1 |
| Gospe, SM | 1 |
| Hecht, ST | 1 |
| Robertson, RT | 1 |
| Annis, CM | 1 |
| Baratta, J | 1 |
| Haraldson, S | 1 |
| Ingeman, J | 1 |
| Kageyama, GH | 1 |
| Kimm, E | 1 |
| Yu, J | 1 |
| Berry, K | 1 |
| Bird, ED | 1 |
| Beal, MF | 1 |
| Ferrante, RJ | 1 |
| Swartz, KJ | 1 |
| Kowall, NW | 1 |
| Schallert, T | 1 |
| Jones, TA | 1 |
| Lindner, MD | 1 |
| Whitehouse, PJ | 1 |
| Muramoto, O | 1 |
| Troncoso, JC | 1 |
| Kanazawa, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Effects of Clinical Pilates Training and Aerobic Exercise on Menopausal Symptoms, Quality of Life, Sleep and Depression[NCT05764031] | 30 participants (Actual) | Interventional | 2020-12-16 | Completed | |||
| NMDA-Receptor Blockade in Huntington's Chorea[NCT00001930] | Phase 2 | 25 participants | Interventional | 1999-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for gamma-aminobutyric acid and Atrophy
| Article | Year |
|---|---|
Systematic review of in-vivo neuro magnetic resonance spectroscopy for the assessment of posttraumatic stress disorder.
Topics: Aspartic Acid; Atrophy; Brain; Creatine; Female; gamma-Aminobutyric Acid; Gyrus Cinguli; Hippocampus | 2018 |
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexa | 2016 |
Pathogenesis of brain dysfunction in Batten disease.
Topics: Animals; Atrophy; Brain; Cerebral Cortex; Dogs; gamma-Aminobutyric Acid; Golgi Apparatus; Humans; Hy | 1995 |
Multilevel transneuronal degeneration after brain damage. Behavioral events and effects of anticonvulsant gamma-aminobutyric acid-related drugs.
Topics: Animals; Atrophy; Behavior, Animal; Cerebrovascular Disorders; Corpus Striatum; Diazepam; gamma-Amin | 1990 |
2 trials available for gamma-aminobutyric acid and Atrophy
| Article | Year |
|---|---|
Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study.
Topics: Acetates; Aged; Amines; Antiparkinson Agents; Atrophy; Cerebellar Ataxia; Cerebellar Cortex; Cyclohe | 2004 |
Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy.
Topics: Adult; Aged; Anticonvulsants; Atrophy; Cerebellar Ataxia; Female; Follow-Up Studies; gamma-Aminobuty | 2007 |
39 other studies available for gamma-aminobutyric acid and Atrophy
| Article | Year |
|---|---|
Swimming and L-arginine loaded chitosan nanoparticles ameliorates aging-induced neuron atrophy, autophagy marker LC3, GABA and BDNF-TrkB pathway in the spinal cord of rats.
Topics: Animals; Antioxidants; Arginine; Atrophy; Autophagy; Brain-Derived Neurotrophic Factor; Chitosan; ga | 2023 |
Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms.
Topics: Atrophy; DiGeorge Syndrome; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Hippocampus; Humans; | 2023 |
Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Choline; Creatine; Disease Progression; | 2019 |
Blocking Astrocytic GABA Restores Synaptic Plasticity in Prefrontal Cortex of Rat Model of Depression.
Topics: Animals; Astrocytes; Atrophy; Depression; Disease Models, Animal; gamma-Aminobutyric Acid; Long-Term | 2020 |
Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons.
Topics: Age Factors; Animals; Atrophy; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; gamma-Amino | 2019 |
Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.
Topics: Animals; Antidepressive Agents; Atrophy; Breath Tests; Cerebral Cortex; Desipramine; GABAergic Neuro | 2016 |
IV and V cranial nerves dysfunction as initial manifestations of superficial siderosis of the central nervous system.
Topics: Aged; Amines; Angiography, Digital Subtraction; Atrophy; Central Nervous System Diseases; Cerebellum | 2016 |
Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion.
Topics: Animals; Astrocytes; Atrophy; Brain; Brain Injuries; Cold Temperature; Cyclic Nucleotide Phosphodies | 2009 |
Gabapentin treatment improves motor coordination in a mice model of progressive ataxia.
Topics: Age Factors; Amines; Analysis of Variance; Animals; Ataxia; Atrophy; Cell Count; Cerebellum; Chromat | 2009 |
Pattern of injury with a graded excitotoxic insult and ensuing chronic medial septal damage in the rat brain.
Topics: Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Astrocytes; Atroph | 2009 |
Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
Topics: Animals; Apoptosis; Atrophy; Brain; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Caspase 3; C | 2010 |
Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Topics: Adult; Aldehyde Oxidoreductases; Atrophy; Cerebellum; Chromatography, High Pressure Liquid; Chromato | 2003 |
Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis.
Topics: Animals; Astrocytes; Atrophy; Disease Models, Animal; Fluorescence; gamma-Aminobutyric Acid; Hippoca | 2004 |
Carbamazepine encephalopathy masquerading as Creutzfeldt-Jakob disease.
Topics: Aged; Amines; Analgesics, Non-Narcotic; Atrophy; Basal Ganglia; Brain; Brain Damage, Chronic; Carbam | 2005 |
Eye movement abnormalities in stiff person syndrome.
Topics: Adult; Atrophy; Brain Stem; Cerebellar Diseases; Cerebellum; Female; gamma-Aminobutyric Acid; Glutam | 2005 |
Clinical correlates of quantitative EEG alterations in alcoholic patients.
Topics: Adult; Age Factors; Aged; Alcohol Withdrawal Seizures; Alcohol-Induced Disorders, Nervous System; Al | 2006 |
Gamma-aminobutyric acid specifically inhibits progression of tubular fibrosis and atrophy in nephrectomized rats.
Topics: Animals; Atrophy; Blood Urea Nitrogen; Creatinine; Disease Progression; Dose-Response Relationship, | 2007 |
Low concentrations of ketamine initiate dendritic atrophy of differentiated GABAergic neurons in culture.
Topics: Animals; Animals, Newborn; Atrophy; Cell Count; Cell Survival; Cells, Cultured; Dendrites; Dizocilpi | 2007 |
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
Topics: Adenosine A2 Receptor Agonists; Animals; Arachidonic Acids; Atrophy; Brain Chemistry; Cannabidiol; C | 2007 |
Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia.
Topics: Amines; Animals; Animals, Newborn; Anticonvulsants; Atrophy; Behavior, Animal; Body Temperature; Bra | 2008 |
Decreased hippocampal volume on MRI is associated with increased extracellular glutamate in epilepsy patients.
Topics: Adolescent; Adult; Atrophy; Chromatography, High Pressure Liquid; Electroencephalography; Epilepsy, | 2008 |
Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration.
Topics: Animals; Arginine; Atrophy; Carrier Proteins; Cell Movement; Choroid; gamma-Aminobutyric Acid; Gluta | 2008 |
Neurotransmitter amino acids in dominantly inherited cerebellar disorders.
Topics: Amino Acids; Aspartic Acid; Atrophy; Cerebellar Diseases; gamma-Aminobutyric Acid; Glutamates; Human | 1981 |
Neurotransmitters and CNS disease. Schizophrenia.
Topics: Antipsychotic Agents; Atrophy; Brain; Cerebral Ventricles; Chronic Disease; Dopamine; Endorphins; GA | 1982 |
[Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
Topics: Acanthocytes; Adult; Aged; Atrophy; Brain Diseases; Chorea; gamma-Aminobutyric Acid; Homovanillic Ac | 1983 |
Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
Topics: Adult; Aged; Alzheimer Disease; Atrophy; Brain Diseases; Female; gamma-Aminobutyric Acid; Humans; Hu | 1984 |
Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy.
Topics: Atrophy; Benzodiazepines; Brain; Brain Diseases; Cerebellar Cortex; Cerebellum; Flunitrazepam; gamma | 1984 |
Localized proton magnetic resonance spectroscopy of cerebral abnormalities in children with carbohydrate-deficient glycoprotein syndrome.
Topics: Atrophy; Brain; Cerebellum; Child; Child, Preschool; Congenital Disorders of Glycosylation; Dandy-Wa | 1995 |
Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements.
Topics: Adult; Atrophy; Autoantibodies; Autoimmunity; Cerebellum; Eye Movements; Female; gamma-Aminobutyric | 1995 |
Vigabatrin monotherapy in resistant neonatal seizures.
Topics: Agenesis of Corpus Callosum; Anticonvulsants; Atrophy; Brain; Cerebral Cortex; Dose-Response Relatio | 1995 |
Adult onset myoclonic Huntington's disease.
Topics: Adult; Atrophy; Cerebral Cortex; Corpus Striatum; Electric Stimulation; Electroencephalography; Elec | 1993 |
[West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment].
Topics: Anticonvulsants; Atrophy; Cerebral Palsy; Cerebral Ventricles; Child; Child, Preschool; Female; gamm | 1997 |
GABA and brain abnormalities in schizophrenia.
Topics: Adult; Analysis of Variance; Atrophy; Brain; Cerebral Ventricles; Chromatography, High Pressure Liqu | 1998 |
Longitudinal MRI findings in pyridoxine-dependent seizures.
Topics: Atrophy; Brain; Child; Child, Preschool; Epilepsy; Female; gamma-Aminobutyric Acid; Glutamate Decarb | 1998 |
Do subplate neurons comprise a transient population of cells in developing neocortex of rats?
Topics: Acetylcholinesterase; Aging; Animals; Animals, Newborn; Atrophy; Biomarkers; Bromodeoxyuridine; Cell | 2000 |
Abnormalities in neurotransmitter amino acids in dominantly inherited cerebellar disorders.
Topics: Amino Acids; Aspartic Acid; Atrophy; Brain Chemistry; Cerebellar Cortex; Cerebellar Diseases; Cerebe | 1978 |
The brain in Huntington's chorea.
Topics: Age Factors; Alzheimer Disease; Atrophy; Basal Ganglia; Brain; Cell Survival; Dopamine; gamma-Aminob | 1978 |
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Atrophy; Biogenic Amines; Cerebra | 1991 |
Neurotransmitter receptors in olivopontocerebellar atrophy: an autoradiographic study.
Topics: Aged; Aspartic Acid; Atrophy; Autoradiography; Binding Sites; Cerebellum; gamma-Aminobutyric Acid; G | 1986 |